🟢 Connect Biopharma is trading 5% up in pre-market amid expected September topline results

Connect Biopharma is trading 5.07% up now at $2.90 in pre-market trading, with ongoing interest possibly supported by expected September topline results; no direct cause was established.

• Shares gained 16.95% on September 2 and 7.27% on September 1.
• The latest company update expects September topline results from both Phase 2 Seabreeze STAT studies.
• No fresh company-specific announcement, earnings release, regulatory action, or trial update dated September 3, 2026, was identified.